Newbridge Financial Services Group’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-308
Closed -$2K – 1368
2022
Q2
$2K Hold
308
– – ﹤0.01% 1149
2022
Q1
$2K Hold
308
– – ﹤0.01% 1261
2021
Q4
$2K Hold
308
– – ﹤0.01% 1210
2021
Q3
$3K Hold
308
– – ﹤0.01% 1090
2021
Q2
$3K Hold
308
– – ﹤0.01% 1193
2021
Q1
$4K Buy
+308
New +$3.66K ﹤0.01% 1054

Other funds holding ACHV

Newbridge Financial Services Group's ACHV Position: Q3 2022 in Review

Newbridge Financial Services Group sold out of Achieve Life Sciences (ACHV) in Q3 2022, closing a stake of 308 shares — an estimated $2K sold.

Newbridge Financial Services Group first reported a position in ACHV in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q1 2021. 28 funds tracked by Wall St. Rank hold ACHV as of Q3 2022.

  • Newbridge Financial Services Group reported no remaining Achieve Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 308 Achieve Life Sciences shares in Q3 2022, an estimated $2K.
  • Newbridge Financial Services Group first reported a position in Achieve Life Sciences in Q1 2021 and held it in 6 quarters.
  • Newbridge Financial Services Group's Achieve Life Sciences position peaked at $4K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2022.

Based on Newbridge Financial Services Group's 13F filing for Q3 2022, filed 13 Oct 2022.